Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe S, French P, Hutton P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TR, Davies L, Shields G, Buck D, Tully S, Kingdon D.
Morrison AP, et al.
Health Technol Assess. 2019 Feb;23(7):1-144. doi: 10.3310/hta23070.
Health Technol Assess. 2019.
PMID: 30806619
Free PMC article.
Clinical Trial.
The health benefit measure for the economic evaluation was the QALY, estimated from the EuroQol-5 Dimensions, five-level version (EQ-5D-5L), health status measure. Service use was measured to estimate costs. ...
The health benefit measure for the economic evaluation was the QALY, estimated from the EuroQol-5 Dimensions, five-level version (EQ-5D …